Rua Releases Annual Report for Year Ended 30 June 2022

ANNREP
Wed, Sep 14 2022 04:18 pm

Rua Bioscience (NZX: RUA) today released its Annual Report for the 12 months ended 30 June 2022 (FY22).

In our Annual Report, we review the strides Rua Bioscience has made in the past 12 months, outline our current performance and share our aspirations for the future. We’ll give you insight into our industry and the ever-changing environment within which we operate as an ambitious medicinal cannabis start-up. We’ll also explore our deep connection to Te Tairāwhiti and the responsibilities we carry as a company established to have a positive impact on our people and our whenua.

The Annual Report is attached and available now on the Rua website www.ruabio.com/investors. Those who have requested it will receive a hard copy in the post in due course.


ENDS


For more information, please visit www.ruabio.com or contact:
Investors
Hamish White
Chief Financial Officer
+64 (21) 050 5795
[email protected]

Media
Kerry Donovan
Communications Manager
+64 (21) 128 7689
[email protected]


Announcement PDF


Markets News

NZ sharemarket edges higher as F&P Healthcare weighs on gains
Markets Market Close

NZ sharemarket edges higher as F&P Healthcare weighs on gains

The S&P/NZX 50 Index closed 14.49 points or 0.11% down at 13,391.59.

Jamie Gray 24 Oct 2025
Finance

Kiwibank wary of capital-review barrier to growth

Kiwibank raises issues of competitive advantage.

Andy Macdonald 24 Oct 2025
Kiwibank wary of capital-review barrier to growth
Primary Sector

Fonterra windfall brings risks: ASB

Farmers will vote for the Lactalis deal on Oct 30.

Rebecca Howard 24 Oct 2025
Fonterra windfall brings risks: ASB